Valeant’s ill CEO Pearson on the ‘road to recovery,’ but still no timeline for his return

Carly Helfand

Valeant's pneumonia-stricken CEO, J. Michael , is on the mend, according to a letter he penned to his colleagues on Monday. But as to when he'll be back at work, it's up in the air.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS